These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 8201680

  • 1. Nephrocalcin in patients with renal cell carcinoma.
    Nakagawa Y, Netzer M, Michaels EK, Suzuki F, Ito H.
    J Urol; 1994 Jul; 152(1):29-34. PubMed ID: 8201680
    [Abstract] [Full Text] [Related]

  • 2. Nephrocalcin: biosynthesis by human renal carcinoma cells in vitro and in vivo.
    Nakagawa Y, Sirivongs D, Novy MB, Netzer MF, Michaels E, Vogelzang NJ, Coe FL.
    Cancer Res; 1992 Mar 15; 52(6):1573-9. PubMed ID: 1540966
    [Abstract] [Full Text] [Related]

  • 3. Properties and function of nephrocalcin: mechanism of kidney stone inhibition or promotion.
    Nakagawa Y.
    Keio J Med; 1997 Mar 15; 46(1):1-9. PubMed ID: 9095576
    [Abstract] [Full Text] [Related]

  • 4. Isolation from human calcium oxalate renal stones of nephrocalcin, a glycoprotein inhibitor of calcium oxalate crystal growth. Evidence that nephrocalcin from patients with calcium oxalate nephrolithiasis is deficient in gamma-carboxyglutamic acid.
    Nakagawa Y, Ahmed M, Hall SL, Deganello S, Coe FL.
    J Clin Invest; 1987 Jun 15; 79(6):1782-7. PubMed ID: 3584470
    [Abstract] [Full Text] [Related]

  • 5. Elucidation of multiple forms of nephrocalcin by 31P-NMR spectrometer.
    Nakagawa Y, Otsuki T, Coe FL.
    FEBS Lett; 1989 Jul 03; 250(2):187-90. PubMed ID: 2753126
    [Abstract] [Full Text] [Related]

  • 6. Immunohistochemical localization of nephrocalcin, a kidney-specific glycoprotein, to renal cell carcinoma.
    Michaels EK, Ghosh L, Nakagawa Y, Netzer MF, Vidal P, Arsenault D, Ito H.
    Urology; 1998 Nov 03; 52(5):920-4. PubMed ID: 9801131
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evidence that mouse renal proximal tubule cells produce nephrocalcin.
    Sirivongs D, Nakagawa Y, Vishny WK, Favus MJ, Coe FL.
    Am J Physiol; 1989 Sep 03; 257(3 Pt 2):F390-8. PubMed ID: 2782421
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Interaction between nephrocalcin and calcium oxalate monohydrate: a structural study.
    Deganello S.
    Calcif Tissue Int; 1991 Jun 03; 48(6):421-8. PubMed ID: 2070277
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Human kidney injury molecule-1 is a tissue and urinary tumor marker of renal cell carcinoma.
    Han WK, Alinani A, Wu CL, Michaelson D, Loda M, McGovern FJ, Thadhani R, Bonventre JV.
    J Am Soc Nephrol; 2005 Apr 03; 16(4):1126-34. PubMed ID: 15744000
    [Abstract] [Full Text] [Related]

  • 17. Isolation of nephrocalcin from kidney tissue of nine vertebrate species.
    Nakagawa Y, Renz CL, Ahmed M, Coe FL.
    Am J Physiol; 1991 Feb 03; 260(2 Pt 2):F243-8. PubMed ID: 1996674
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.